Trials / Sponsors / InCarda Therapeutics, Inc.
InCarda Therapeutics, Inc.
Industry · 2 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Terminated | Flecainide Acetate Inhalation Solution for Cardioversion of Recent-Onset, Symptomatic Atrial Fibrillation Paroxysmal Atrial Fibrillation | Phase 3 | 2022-04-26 |
| Completed | INhalation of Flecainide to Convert Recent Onset SympTomatic Atrial Fibrillation to siNus rhyThm (INSTANT) Paroxysmal Atrial Fibrillation (PAF) | Phase 2 | 2018-05-29 |